or Try an Advanced Search...

    ETF Components for EDEN - iShares MSCI Denmark Capped ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NVO F -0.89 22.75
    TRMD F -5.12 0.97

    Represented by ETF Holdings

    Keywords: Anti Diabetic Drugs Biopharmaceutical Bulk Carrier Chemical Substances Diabetes Diabetes Care Endocrine System Gas Oil Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hormone Therapy Hormones IBD 50 Inflammation Insulin Life Sciences Liquid Fuels Obesity
    Industries: Biotechnology Shipping & Ports

    Recent News for iShares MSCI Denmark Capped ETF & its Holdings

    Date Stock Title
    Oct 1 NVO Novo Nordisk (NVO) Stock Moves -0.89%: What You Should Know
    Oct 1 NVO U.S. port strike expected to have limited impact on healthcare supply chain: HHS
    Oct 1 NVO Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports
    Sep 30 NVO Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
    Sep 30 NVO Is Novo Nordisk A/S (NYSE:NVO) The Top Global Stock To Buy Now?
    Sep 29 NVO Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
    Sep 29 NVO 'Stop Ripping Us Off' – Incredibly, Elon Musk And Bernie Sanders Seem To Agree On This One Thing – 'I Really Am With Bernie On This One'
    Sep 28 NVO 15 Unhealthiest Countries in Europe
    Sep 28 NVO Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
    Sep 28 NVO Benzinga Bulls And Bears: Apple, Tesla, Novo Nordisk, Bitcoin — And Shiba Inu's Major Stablecoin Tease
    Sep 27 NVO Novo Nordisk stock closes lower, analyst warns about Wegovy sales
    Sep 27 NVO Top Midday Stories: Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug; Novo Nordisk Shares Drop After Analyst's Sales Concerns
    Sep 27 NVO Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales
    Sep 27 NVO Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
    Sep 27 NVO Novo Nordisk’s Wegovy-Fueled Gains Fading as Analyst Doubts Grow
    Sep 27 NVO Compounding pharmacies caught in counterfeit controversy
    Sep 26 NVO Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development
    Sep 26 NVO The Zacks Analyst Blog Highlights Broadcom, Novo Nordisk, ConocoPhillips, Smith-Midland Corp. and Tredegar
    Sep 26 NVO Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
    Sep 26 NVO EADV 2024: Wegovy shows promise in treating common, chronic skin condition
    The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Denmark IMI 25/50 Index (the "underlying index"). The fund will at all times invest at least 90% of its assets in the securities of the underlying index or in depositary receipts representing securities in its underlying index. The underlying index is designed to measure broad-based equity market performance in Denmark. A capping methodology is applied that limits the weight of any single component to a maximum of 25% of the underlying index. The fund is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Bond Market MSCI EAFE
    Back to the Main EDEN Page...